PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of oncotargetLink to Publisher's site
 
Oncotarget. 2017 February 28; 8(9): 16099.
Published online 2017 February 27. doi:  10.18632/oncotarget.15755
PMCID: PMC5362548

Correction: Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors

Present: The currently listed corresponding author, John C. Herr, is deceased. Oncotarget wishes to express our condolences to his family and colleagues.

Corrected: The new correspondence author information is as follows.

Original article: Oncotarget. 2015; 6(30):30194-211. doi: 10.18632/oncotarget.4734.

Correspondence to: Eusebio S. Pires, email: moc.liamg@seripoibesue


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC